The adoption of recombinant antibodies has been on the rise, driven by their extensively documented benefits such as improved specificity, sensitivity, and reproducibility. If you find yourself among those hesitant to make the shift from conventional monoclonal and polyclonal antibodies, whether because of uncertainty about the advantages, a reliance on literature precedents, laboratory preferences, cost concerns, or other scientific considerations, download this infographic now. It can assist you in determining whether recombinant antibodies align with your experimental requirements.
Get infographic